Industry News

SynBioBeta brings you the latest news weekly to help you stay informed and learn about the latest developments in the synthetic biology industry. Subscribe to receive the latest news weekly to your inbox. Have news to share? Contact us to submit your story.


Stay Updated on the Latest News in Synthetic Biology

Subscribe to the Weekly SynBioBeta Digest

Latest News

September 2017

3rd Annual Engineering Biology Award Winners Announced

Meet Jacob Glanville, a scientist and entrepreneur pioneering the next generation of biomedicine

Berkeley Lights Announces Strategic Project with Bayer Focused on Cell Line Development and Antibody Discovery

Horizon Discovery announces launch of Genome-Wide CRISPRi and CRISPRa Screening Services

LifeMine Therapeutics Launches with $55 Million Series A Financing

Elemental Machines Wins MassTLC Leadership Award for Innovative Technology of the Year: IoT

Guesstimating the Size of the Global Array Synthesis Market

How to Restore our Oceans with Biotechnology: Meet BioCellection

Sugars Worth Getting Addicted to: Meet Sugarlogix

A $200M Dollar Mistake: Why It’s Best To Be Patient With CRISPR

Why M Ventures is Investing in Synthetic Biology Companies – Meet Andreas Jurgeit

Unleashing the Power of Engineered Proteins: The Possibilities are Endless

Sean O’Sullivan at IndieBio’s 5th Demo Day

The AGIR project carried out by the DEINOVE group is granted €14.6 million by the ‘Investments for the Future’ Program (IFP) operated by Bpifrance to develop new antibiotics.

GreenLight Biosciences Announces Series D Financing, Unveils RNA Strategy

Bayer and Ginkgo Bioworks join forces for sustainable agriculture, forming new company with USD 100 million Series A

Arcadia Biosciences To Accelerate Agricultural Trait Development with CRISPR-Cas9

Bioeconomy Fund 1 completes $8.3M of investments in six companies that are building critical infrastructure for the 21st century global economy.

Benson Hill Biosystems Launches Novel Genome Editing CRISPR 3.0 Technology

DNA Script raises €11 million ($13 million) in series A financing led by Illumina Ventures to advance development of its DNA synthesis technology